<SEC-DOCUMENT>0001193125-23-279846-index.html : 20231117
<SEC-HEADER>0001193125-23-279846.hdr.sgml : 20231117
<ACCEPTANCE-DATETIME>20231117164403
ACCESSION NUMBER:		0001193125-23-279846
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20231117
DATE AS OF CHANGE:		20231117
EFFECTIVENESS DATE:		20231117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tempest Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001544227
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				451472564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264943
		FILM NUMBER:		231419449

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		415-798-8589

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Millendo Therapeutics, Inc.
		DATE OF NAME CHANGE:	20181207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OvaScience, Inc.
		DATE OF NAME CHANGE:	20120308
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>d599420ds8pos.htm
<DESCRIPTION>S-8 POS
<TEXT>
Document 1 - file: d599420ds8pos.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d599420dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d599420dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d599420dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: d599420dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g599420g1117003341370.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g599420g1117003341370.jpg

</DOCUMENT>
</SEC-DOCUMENT>